MNL-00008 [5]
Proprietary and Confidential Page
46
of
55
Skin Type
I
II
III
IV
V
VI
MED RANGE
20-60 mJ 30-75 mJ 40-90 mJ 50-110 mJ 60-120 mJ 70-140 mJ
DOSE LIMITS with WARNING
1400 mJ
1700 mJ
2000 mJ
2500 mJ
2700 mJ
3100 mJ
SYSTEM DOSE LIMITS
1600 mJ
1900 mJ
2200 mJ
2700 mJ
3000 mJ
3400 mJ
23.10
LO Dose Narrow Band UVB Clearing Phase Protocols: 11011, 3/week, 2/week
Maximum Number of Treatments = 29
ALL SKIN TYPES, ALL SCHEDULES
% of
MED
% INCREASE OVER PREVIOUS DOSE
TREATMENT #
1
2
3
4
5
6
7
8
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
29
PRIMARY DOSE (MILLIJOULES)
30
20 19 18 17 16 15 14 13 12 11 10 9
8
7
6
5
4
3
2
1
0
0
0
0
0
0
0
0
% OF PRIMARY DOSE
SECONDARY DOSE (MILLIJOULES)
50
50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50
50
23.11
LO Dose Narrow Band UVB Maintenance Phase Protocols: 1/WEEK
Maximum Number of Treatments = 4
ALL SKIN TYPES:
Dose should be held steady at last clearance phase dose.
23.12
LO Dose Narrow Band UVB Treatment Limits for Maintenance & As Required Protocols
Skin Type
I
II
III
IV
V
VI
MED RANGE
50-300 mJ 100-400 mJ 150-500 mJ 200-600 mJ 250-700 mJ 300-800 mJ
DOSE LIMITS with WARNING
800 mJ
1100 mJ
1300 mJ
1600 mJ
1800 mJ
2100 mJ
SYSTEM DOSE LIMITS
1000 mJ
1400 mJ
1700 mJ
2000 mJ
2300 mJ
2700 mJ
23.13
HI Dose Narrow Band UVB Clearing Phase Protocols:
11011, 3/week, 2/week
